Anne-Marie Koop

116 Author Year Title PMID Embase Accession ID Piao, et al. 57 2013 FOXO1-mediated upregulation of pyruvate 23247844 x dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. Gomez- 2013 Metabolic gene remodeling and 23152488 x Arroyo, et al. 58 mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Friehs, et al. 59 2013 Pressure-overload hypertrophy of the 23262132 x developing heart reveals activation of divergent gene and protein pathways in the left and right ventricular myocardium. Enache, et 2013 Skeletal muscle mitochondrial dysfunction 23099843 x al. 60 precedes right ventricular impairment in experimental pulmonary hypertension. Kojonazarov, 2013 The peroxisome proliferator-activated 25006409 x et al. 61 receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy. Yoshinaga, 2013 Attenuated right ventricular energetics 24615469 et al. 62 evaluated using ¹¹C-acetate PET in patients with pulmonary hypertension. Wang, et al. 63 2013 Evaluation of right ventricular volume and 23354658 ejection fraction by gated (18)F-FDG PET in patients with pulmonary hypertension: comparison with cardiac MRI and CT. Lundgrin, et 2013 Fasting 2-deoxy-2-[18F]fluoro-D-glucose 23509326 al. 64 positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. Ikeda, et al. 65 2014 Crucial role of rho-kinase in pressure 24675663 2014358537 overload-induced right ventricular hypertrophy and dysfunction in mice.